Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deep Knowledge Investors appears to refer to the investment and investor-facing activities associated with the Deep Knowledge ecosystem, which includes Deep Knowledge Group and its investment arm Deep Knowledge Ventures. The organization is not a drug developer, pharma company, or healthcare operating company; instead, it focuses on investment, analytics, and capital formation around DeepTech, longevity, biotech, pharma, and related healthcare sectors. Public materials describe Deep Knowledge Ventures as a data-driven investment fund founded in 2014 and Deep Knowledge Group as a broader consortium spanning analytics, investment, and media in AI, longevity, biotech, and pharma. In practice, this entity is best characterized as a healthcare- and longevity-oriented investment organization rather than a therapeutics company with an internal pipeline. Because the exact legal entity name "Deep Knowledge Investors" is not well documented in primary public sources, some fields below are inferred from the broader Deep Knowledge Group / Deep Knowledge Ventures structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deep Knowledge Investors.